ClinConnect ClinConnect Logo
Search / Trial NCT05950282

Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Launched by LILLI HEALTH · Jul 10, 2023

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

Pcos Hyperinsulinemia Insulin Resistance Metabolic Syndrome Obesity Type 2 Diabetes

ClinConnect Summary

This clinical trial is studying how different factors like age, sex, race, body weight (BMI), and having polycystic ovary syndrome (PCOS) affect levels of insulin in the body. Insulin is a hormone that helps control blood sugar, and understanding these relationships can help us learn more about conditions like insulin resistance, obesity, and metabolic syndrome. Researchers are particularly interested in how these factors may change insulin levels and overall metabolic health.

To participate in this study, you need to be at least 18 years old, and both men and women are welcome to join. The trial seeks individuals from various racial and ethnic backgrounds, and they are looking for participants with a wide range of body weights, including those with and without a diagnosis of PCOS. If you join, you can expect to provide information about your health and undergo some tests related to insulin levels. This study is still recruiting participants, so if you're interested, it could be a great opportunity to contribute to important research that may improve understanding of insulin-related health issues.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age: Participants aged 18+ years.
  • Sex: Both males and females.
  • Race/Ethnicity: Participants from diverse racial and ethnic backgrounds
  • BMI: Participants with a range of body mass index (BMI) values
  • PCOS Diagnosis: Participants with and without a confirmed diagnosis PCOS based on established diagnostic criteria.
  • Exclusion Criteria:
  • Age: Participants below 18 years
  • Sex: None. Both males and females are included.
  • Race/Ethnicity: None. Participants from all racial and ethnic backgrounds are included.
  • Endocrine Disorders: Participants with other endocrine disorders affecting insulin levels, such an insulin secreting tumor.

About Lilli Health

Lilli Health is a pioneering clinical trial sponsor dedicated to advancing women's health through innovative research and development. With a strong focus on addressing unmet medical needs, Lilli Health collaborates with leading healthcare professionals and research institutions to conduct rigorous clinical trials that prioritize patient safety and efficacy. The organization leverages cutting-edge technologies and patient-centric approaches to ensure that its trials are not only scientifically robust but also accessible and relevant to the diverse populations they serve. Committed to transparency and ethical practices, Lilli Health aims to contribute significantly to the advancement of healthcare solutions that empower women and improve their quality of life.

Locations

Houston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Ali M Chappell

Principal Investigator

Lilli Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported